Breath Diagnostics, Inc.
1 known investors
Find your way into Breath Diagnostics, Inc.
Sign up to find every way you can get introduced to Breath Diagnostics, Inc.
- Your email: who you already know at Breath Diagnostics, Inc., and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Breath Diagnostics, Inc. team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Breath Diagnostics develops OneBreath, a non-invasive breath test that captures volatile organic compounds from a single exhale and analyzes them with microreactor chemistry and mass spectrometry to detect early-stage lung cancer. The test is aimed at at-risk patients such as smokers and is designed for use in clinics, pharmacies, and community health settings.
Investors · 1
In the news
Frequently asked questions
- What does Breath Diagnostics, Inc. do?
- Breath Diagnostics develops OneBreath, a non-invasive breath test that captures volatile organic compounds from a single exhale and analyzes them with microreactor chemistry and mass spectrometry to detect early-stage lung cancer. The test is aimed at at-risk patients such as smokers and is designed for use in clinics, pharmacies, and community health settings.
- Who are Breath Diagnostics, Inc.'s investors?
- Breath Diagnostics, Inc.'s investors include HealthXCapital.